Parallax Volatility Advisers’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,156
Closed -$1.24M 1960
2024
Q1
$1.24M Buy
+8,156
New +$1.36M ﹤0.01% 1174
2023
Q2
Sell
-7,556
Closed -$4.49M 2343
2023
Q1
$4.49M Buy
7,556
+5,452
+259% +$3.05M 0.01% 911
2022
Q4
$849K Buy
2,104
+1,360
+183% +$638K ﹤0.01% 1718
2022
Q3
$436K Buy
744
+100
+16% +$59.9K ﹤0.01% 2020
2022
Q2
$351K Buy
+644
New +$326K ﹤0.01% 2037

Other funds holding AGL

Parallax Volatility Advisers's AGL Position: Q2 2024 in Review

Parallax Volatility Advisers sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 7,253 shares — an estimated $1.11M sold.

Parallax Volatility Advisers first reported a position in AGL in Q2 2022 and held it in 5 quarters. The position peaked at $1.11M in Q1 2024. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

  • Parallax Volatility Advisers reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 7,253 Agilon Health shares in Q2 2024, an estimated $1.11M.
  • Parallax Volatility Advisers first reported a position in Agilon Health in Q2 2022 and held it in 5 quarters.
  • Parallax Volatility Advisers's Agilon Health position peaked at $1.11M in Q1 2024.
  • 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on Parallax Volatility Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.